Elutia Inc. (ELUT) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Elutia Inc. stock (ELUT) is currently trading at $1.06. Elutia Inc. PS ratio (Price-to-Sales) is 3.83. Analyst consensus price target for ELUT is $5.00. WallStSmart rates ELUT as Sell.
- ELUT PE ratio analysis and historical PE chart
- ELUT PS ratio (Price-to-Sales) history and trend
- ELUT intrinsic value — DCF, Graham Number, EPV models
- ELUT stock price prediction 2025 2026 2027 2028 2029 2030
- ELUT fair value vs current price
- ELUT insider transactions and insider buying
- Is ELUT undervalued or overvalued?
- Elutia Inc. financial analysis — revenue, earnings, cash flow
- ELUT Piotroski F-Score and Altman Z-Score
- ELUT analyst price target and Smart Rating
Elutia Inc.
📊 No data available
Try selecting a different time range
Smart Analysis
Elutia Inc. (ELUT) · 7 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/book, profit margin. Concerns around market cap and operating margin. Mixed signals suggest waiting for clearer direction before acting.
Elutia Inc. (ELUT) Key Strengths (2)
Keeps $434 of every $100 in revenue as net profit
Trading at 1.70x book value, attractively priced
Supporting Valuation Data
Elutia Inc. (ELUT) Areas to Watch (5)
Losing money on operations
Micro-cap company with very limited liquidity and high volatility
Revenue is fairly priced at 3.83x sales
Solid revenue growth at 16.20% per year
Moderate institutional interest at 49.25%
Elutia Inc. (ELUT) Detailed Analysis Report
Overall Assessment
This company scores 40/100 in our Smart Analysis, earning a D grade. Out of 7 metrics analyzed, 2 register as strengths (avg 9.0/10) while 5 fall into concern territory (avg 4.2/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Profit Margin, Price/Book. Valuation metrics including Price/Book (1.70) suggest the stock is attractively priced. Profitability is solid with Profit Margin at 434.20%.
The Bear Case
The primary concerns are Operating Margin, Market Cap, Price/Sales. Some valuation metrics including Price/Sales (3.83) suggest expensive pricing. Growth concerns include Revenue Growth at 16.20%, which may limit upside. Profitability pressure is visible in Operating Margin at -167.90%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Operating Margin improves, as this is the primary drag on the overall score. Second, margin trajectory, with Operating Margin at -167.90% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 16.20% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Operating Margin and Market Cap are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
ELUT Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
ELUT's Price-to-Sales ratio of 3.83x trades 31% below its historical average of 5.51x (36th percentile). The current valuation is 75% below its historical high of 15.3x set in Jan 2021, and 325% above its historical low of 0.9x in Dec 2025. Over the past 12 months, the PS ratio has compressed from ~4.4x as trailing revenue scaled faster than the stock price.
WallStSmart Analysis Synopsis
Data-driven financial summary for Elutia Inc. (ELUT) · HEALTHCARE › MEDICAL DEVICES
The Big Picture
Elutia Inc. is a strong growth company balancing expansion with improving profitability. Revenue reached 12M with 16% growth year-over-year. Profit margins are strong at 434.2%, reflecting pricing power and operational efficiency.
Key Findings
Free cash flow is -25M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Sector dynamics: monitor MEDICAL DEVICES industry trends, competitive moves, and regulatory changes that could impact Elutia Inc..
Bottom Line
Elutia Inc. offers an attractive blend of growth (16% revenue expansion) and improving fundamentals. The company is transitioning from pure growth to profitable growth, a critical inflection point. Watch for sustained margin expansion as the key signal.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Elutia Inc.(ELUT)
NASDAQ
HEALTHCARE
MEDICAL DEVICES
USA
Elutia Inc., a commercial-stage company, engages in developing and commercializing drug-eluting biomatrix technology to enhance surgical outcomes. The company is headquartered in Silver Spring, Maryland.